I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Unity Biotechnology (UBX). The reason why I believe that this is another good biotech to go ...
Unity Biotech ( (UBX)) has released its Q3 earnings. Here is a breakdown of the information Unity Biotech presented to its investors. Unity Biotechnology, Inc., a biotechnology company, focuses on ...
Unity Biotech (UBX) has disclosed a new risk, in the Regulation category. Unity Biotech faces significant risks due to potential noncompliance with regulatory standards, which could severely impact ...
SOUTH SAN FRANCISCO, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of ...
Unity Biotechnology and Mammoth Biosciences are both turning toward cost-saving measures, prompting layoffs at both companies. Unity’s restructuring comes along with 36-week results from its phase 2b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results